Direct compression of Baotai Wuyou Powder into oral tablets for swine and companion animals is typically attempted only after a preformulation evaluation of the raw powder. A lot with d90 > 250 µm and a Carr index above 28 or Hausner ratio above 1.35 usually requires wet or dry granulation because direct compression tablets exhibit tensile strength below 1.0 MPa and capping at production speeds above 40 rpm on rotary presses. In direct compression, the API is geometrically diluted with direct-compressible microcrystalline cellulose and pregelatinized starch to a target API content of 20–40% w/w; colloidal silicon dioxide at 0.5–1.0% w/w is added as a glidant before the final blending step, and magnesium stearate is added for the final 3–5 min at 0.5% w/w to avoid over-lubrication. Compression on a 12-station rotary tablet press with 8 mm round concave tooling is run with main compression force between 8 kN and 18 kN; tablet hardness is maintained between 60 N and 100 N, friability is held below 1.0% under USP <1216>, and disintegration is confirmed under USP <701> with water at 37±2 °C. If direct compression cannot meet USP <905> uniformity acceptance due to segregation, the process is switched to dry granulation through a roller compactor with roll gap 1.0–2.5 mm and granulation integrated with an oscillating mill; this generally reduces fill-weight RSD to below 3.0% in validation batches. Mass uniformity is additionally checked by Ph. Eur. <2.9.5> when the EU monograph applies. The immediate-release tablet must also justify its dissolution method during development, and if published data for this specific herbal API in the target dissolution medium are limited, a USP <711> screen in pH 1.2, pH 4.5, and pH 6.8 buffers should be generated before the method is fixed.

What Filtration Train and Terminal Sterilization Sequence Apply to Injectable Solutions Containing Baotai Wuyou Powder?

For parenteral presentations intended for cattle, swine, and companion species, the manufacturing flow is dictated by the thermal stability of the finished solution. If moist-heat stability has been demonstrated, terminal sterilization in an autoclave at 121 °C for 15 min with an F0 value not less than 15 min is preferred because it eliminates the aseptic fill risk; however, if the API degrades more than 2.0% total related substances during a forced-degradation study in the final vehicle, the batch is switched to a sterilizing-grade filtration route. In the filtration route, the bulk solution is compounded in 316L stainless steel vessels under nitrogen overlay, adjusted to pH 6.5–7.5 with citrate or phosphate buffer, and brought to an osmolality of 280–330 mOsm/kg with sodium chloride or mannitol. The solution is passed through a 0.45 µm polyethersulfone clarification filter followed by a 0.22 µm sterilizing-grade PVDF filter; pre-filtration bioburden is controlled below 10 CFU/100 mL by sampling before the sterilizing filter, and filter integrity is tested by bubble point or water intrusion before and after filling. The sterilizing filter is validated for bacterial retention per ASTM F838-20 with the actual product matrix or a worst-case surrogate. Filling is performed on an aseptic line with peristaltic or rotary piston pumps into depyrogenated glass vials, with target overfill of 5–15% depending on container geometry; the filled units are inspected under USP <790> for visible particulates and tested according to USP <788> for subvisible particulate matter, and bacterial endotoxin limits are set per the intended route of administration, typically tested under USP <85>. Because the API is a dry botanical-origin powder, the compounding temperature should not exceed 40 °C to avoid precipitation of poorly soluble fractions, and the solution should be held in the filling vessel no longer than 12 h unless solution stability data support a longer in-process hold.

Hard Gelatin Capsule Filling Requires Segregation-Resistant Blends at Low Fill Weights

Encapsulation of Baotai Wuyou Powder for companion-animal dosing is constrained less by chemical stability than by powder flow and fill-weight variation. A formulation intended for hard gelatin or HPMC capsules should be granulated when the API fraction contributes more than 40% w/w to the blend or when the blend has a flow function coefficient below 4; otherwise, a plug-type dosator bowl will exhibit bridging and fill-weight RSD above 3.5% at production speeds of 30,000–60,000 capsules/h. The API is first mixed with lactose monohydrate and croscarmellose sodium in a bin blender, then water or a povidone K30 solution is added in a high-shear granulator to produce granules with a target size of 0.3–0.8 mm after drying at product temperature 35–45 °C. The dried granules are milled through a 1.0 mm screen and blended with magnesium stearate for 3 min, and the final blend is filled into size 0 or size 1 capsules. Fill weight is monitored gravimetrically at intervals not exceeding 15 min, and uniformity of dosage units is assessed by USP <905> or Ph. Eur. <2.9.40> for EU-bound batches. Dissolution is tested under USP <711> with sinkers in 900 mL of pH 6.8 phosphate buffer at 37±0.5 °C; if the API has low intrinsic solubility in this medium, a surfactant such as 0.1% w/v polysorbate 80 may be added to the dissolution medium under method justification, not to the formulation. Because capsule shells can embrittle below 40% RH and soften above 70% RH during manufacturing, environmental controls in the encapsulation suite are maintained at 45–55% RH and 20–25 °C unless the product is packaged in aluminum-PVC blister packs immediately after filling.

In-feed premix production at a commercial feed mill places Baotai Wuyou Powder into a high-dilution system where active carryover and mixer efficiency determine field uniformity. The API is first prepared as a Type B medicated article or farm premix by geometric dilution with ground corn, soybean meal, or calcium carbonate at a ratio of 1:10, then 1:100, until the final labeled concentration in Type C medicated feed is reached. Ribbon mixers with working capacity between 50% and 70% of gross volume are preferred; the experimental mixer time is validated by sampling 10 locations after 3, 5, and 7 min and computing the coefficient of variation for the active marker, which should not exceed 5.0% for a Type B medicated article under 21 CFR 558.3-aligned programs and 21 CFR Part 225 medicated feed GMP expectations. The finished premix is bagged in moisture-resistant paper or woven polypropylene with a polyethylene liner, and retained samples are stored at 25±2 °C and 60±5% RH for the shelf-life protocol. Process challenges arise when ambient relative humidity falls below 30% RH, because electrostatic adhesion of the API to stainless steel and polyethylene surfaces can remove 2–5% of the nominal dose from the batch; this is controlled by bonding and grounding dust-handling equipment and by introducing the API through a screened hopper rather than an open charge port. Flush cycles with clean carrier after every medicated batch are validated by residue testing, and a batch-to-batch cleanup limit of not more than 1.0 mg/kg of active marker in the next non-medicated feed is commonly applied unless client specifications are more restrictive.

Drinking-Water Soluble Powder Reconstitution and Farm-Side Dosing

Formulation of Baotai Wuyou Powder as a water-soluble powder for poultry or swine requires that the API vehicle be fully dispersible in farm water within 5 min at 20±2 °C without blocking nipple drinkers or proportioner pumps. The powder is produced by blending the API with dextrose monohydrate, citric acid, and polyvinylpyrrolidone to achieve a target in-use concentration of 0.5–1.0 g/L; citric acid is added at 0.3–0.6% w/w to lower the final solution pH to 6.0–7.0, which improves solubility and reduces precipitation in limestone-alkaline water. Before release, a 20 g sample is stirred into 20 L of standardized hard water at 25 °C with a laboratory paddle mixer; the resulting solution is filtered through a 150 µm sieve, and the retained mass must be below 0.1% of the powder charge. Particle size distribution is checked by analytical sieving according to Ph. Eur. <2.9.12> to ensure that oversized particles do not reach farm-side watering systems. Because free chlorine above 2 ppm can oxidize botanical polyphenolic fractions during the 24 h in-tank use period, the farm-side water supply is tested for chlorine residue before administration; if residual chlorine exceeds the limit, the solution is prepared in a separate tank after dechlorination or the dosing interval is shortened to 12 h. The finished powder is filled into laminate pouches at 25±2 °C and 30–40% RH to prevent moisture uptake, and loss on drying is controlled below 3.0% by Karl Fischer titration or oven drying at 105 °C.

When Baotai Wuyou Powder Is Formulated as a Non-Sterile Oral Solution for Neonatal Ruminants

For calves and lambs in the first 28 days of life, a non-sterile oral solution or suspension may be preferred because the dose can be adjusted to body weight more accurately than with feed or water delivery. The vehicle is prepared with purified water, sorbitol solution at 10–20% w/w, and propylene glycol at 5–10% w/w to improve solubility and mouth feel; methylparaben at 0.18% w/w and propylparaben at 0.02% w/w are included as preservatives, and the pH is adjusted to 5.5–7.5 with dilute hydrochloric acid or sodium hydroxide. The API is dispersed under high-shear mixing in a rotor-stator mixer at 3,000–6,000 rpm for 15–30 min, then passed through a 0.5 mm inline screen before filling into HDPE bottles or amber PET bottles. Viscosity is adjusted with xanthan gum or carboxymethyl cellulose to a target of 50–200 mPa·s at 25 °C; this range is low enough for oral dosing pumps but high enough to reduce sedimentation in stopper-sealed bottles. Preservative effectiveness is evaluated under USP <51>, and the formulation is stored in a stability chamber at 25±2 °C and 60±5% RH for the assigned shelf life. The main process limitation is foam generation during high-shear mixing of botanical powders with surfactant-like saponin fractions, which can generate a head of 10–30% of batch volume; adding simethicone emulsion at 0.01–0.05% w/w before homogenization reduces foam without altering the preservative assay.

If a granular presentation is required for feed top dressing or sachet dosing, Baotai Wuyou Powder is granulated in a fluid-bed dryer with top-spray binder. Inlet air temperature is set at 55–70 °C, product temperature is held at 30–40 °C, and a povidone K30 binder solution is sprayed at 10–25 g/min/kg of dry powder; the resulting granules are dried to a loss on drying below 2.5% and passed through a 0.8 mm screen. The granulated material is filled into heat-sealed sachets at 25±2 °C and 35–45% RH. Batch-to-batch granule density is controlled by tapped density measurement under Ph. Eur. <2.9.34> or USP <616>, and the target bulk density is 0.45–0.65 g/mL to ensure dosing-spoon uniformity. If the API is blended with sweetener and flavoring for oral administration to pigs, the final mixing step should be performed in a low-shear tumble blender at 60±5% of vessel volume for 20 min; mixing longer than 30 min can cause attrition of brittle granules and generate fines that segregate during packaging.